Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
107.12
(
1.93%
)
Bitcoin
68,234.00
(
-0.95%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 131992

Tuesday, 11/29/2011 8:35:26 PM

Tuesday, November 29, 2011 8:35:26 PM

Post# of 257269

In this fluff PR from INHX, the only clinical news of consequence (IMO) is that INHX will begin testing INX-005, a single-isomer version of INX-189:

finance.yahoo.com/news/Inhibitex-Reports-Recent-bw-1609045094.html?x=0

VRUS’ PSI-7977 is a single-isomer drug, and everything INHX is doing and saying strikes me as a transparent attempt to position INHX for investors as the “next” VRUS.

Is it safe to assume that IDX184 is a single-isomer?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today